Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
NNOX Stock Forecast 2026-2027
$1.93
Current Price
$134.31M
Market Cap
Buy 3
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to NNOX Price Targets
+397.4%
To High Target of $9.60
+262.7%
To Median Target of $7.00
+159.1%
To Low Target of $5.00
NNOX Price Momentum
+0.5%
1 Week Change
+9.7%
1 Month Change
-65.1%
1 Year Change
-31.1%
Year-to-Date Change
-66.3%
From 52W High of $5.72
+21.4%
From 52W Low of $1.59
📊 TOP ANALYST CALLS
Did NNOX Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Nano-X is one of their latest high-conviction picks.
Latest NNOX Stock Price Targets & Analyst Predictions
Based on our analysis of 6 Wall Street analysts, NNOX has a bullish consensus with a median price target of $7.00 (ranging from $5.00 to $9.60). The overall analyst rating is Strong Buy (10.0/10). Currently trading at $1.93, the median forecast implies a 262.7% upside. This outlook is supported by 3 Buy, 0 Hold, and 0 Sell ratings.
Conversely, the most conservative target is provided by Jason Kolbert at D. Boral Capital, suggesting a 159.1% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
NNOX Analyst Ratings
3
Buy
0
Hold
0
Sell
NNOX Price Target Range
Low
$5.00
Average
$7.00
High
$9.60
Current: $1.93
Latest NNOX Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for NNOX.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Apr 20, 2026 | D. Boral Capital | Jason Kolbert | Buy | Maintains | $5.00 |
| Apr 13, 2026 | D. Boral Capital | Jason Kolbert | Buy | Maintains | $5.00 |
| Mar 3, 2026 | D. Boral Capital | Buy | Maintains | $N/A | |
| Feb 4, 2026 | D. Boral Capital | Buy | Maintains | $N/A | |
| Nov 20, 2025 | D. Boral Capital | Buy | Maintains | $N/A | |
| Nov 18, 2025 | D. Boral Capital | Buy | Maintains | $N/A | |
| Sep 19, 2025 | D. Boral Capital | Buy | Maintains | $N/A | |
| Aug 13, 2025 | D. Boral Capital | Buy | Maintains | $N/A | |
| Jun 6, 2025 | D. Boral Capital | Buy | Maintains | $N/A | |
| May 23, 2025 | D. Boral Capital | Buy | Maintains | $N/A | |
| Apr 17, 2025 | D. Boral Capital | Buy | Maintains | $N/A | |
| Apr 1, 2025 | Cantor Fitzgerald | Overweight | Maintains | $N/A | |
| Mar 31, 2025 | D. Boral Capital | Buy | Maintains | $N/A | |
| Feb 25, 2025 | D. Boral Capital | Buy | Maintains | $N/A | |
| Jan 6, 2025 | D. Boral Capital | Buy | Initiates | $N/A | |
| Dec 6, 2024 | Cantor Fitzgerald | Overweight | Maintains | $N/A | |
| Nov 26, 2024 | Cantor Fitzgerald | Overweight | Maintains | $N/A | |
| Sep 23, 2024 | Cantor Fitzgerald | Overweight | Reiterates | $N/A | |
| May 31, 2024 | Cantor Fitzgerald | Overweight | Reiterates | $N/A | |
| May 30, 2024 | Cantor Fitzgerald | Overweight | Maintains | $N/A |
Nano-X Imaging Ltd. (NNOX) Competitors
The following stocks are similar to Nano-X based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Nano-X Imaging Ltd. (NNOX) Financial Data
Nano-X Imaging Ltd. has a market capitalization of $134.31M with a P/E ratio of -1.7x. The company generates $13.02M in trailing twelve-month revenue with a -98.2% profit margin.
Revenue growth is +24.0% quarter-over-quarter, while maintaining an operating margin of -479.3% and return on equity of -45.6%.
Valuation Metrics
Market Cap
$134.31M
Enterprise Value
$82.55M
P/E Ratio
-1.7x
PEG Ratio
0.0x
Price/Sales
10.3x
Growth & Margins
Revenue Growth (YoY)
+24.0%
Gross Margin
-97.3%
Operating Margin
-479.3%
Net Margin
-98.2%
EPS Growth
N/A
Financial Health
Cash/Price Ratio
+44.4%
Current Ratio
4.0x
Debt/Equity
5.6x
ROE
-45.6%
ROA
-20.4%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Nano-X Imaging Ltd. (NNOX) Business Model
About Nano-X Imaging Ltd.
What They Do
Innovative medical imaging solutions and technologies.
Business Model
The company develops and commercializes advanced X-ray systems, including the Nanox.ARC and Nanox.CLOUD. It generates revenue through the sale of its imaging systems and cloud-based analytics services, aimed at improving healthcare delivery and early disease detection.
Additional Information
Nano-X Imaging targets to make medical imaging more accessible and affordable, particularly in underserved areas, thereby contributing to global health initiatives. Its focus on integrating AI with imaging technology positions it uniquely in the medical devices sector.
Company Information
Sector
Healthcare
Industry
Medical Devices
Employees
197
CEO
Mr. Erez I. Meltzer
Country
Israel
IPO Year
N/A
Website
www.nanox.visionNano-X Imaging Ltd. (NNOX) Latest News & Analysis
Latest News
Quick Summary
Nanox Imaging Ltd. has signed a distribution agreement with Top Med SAC for deploying six Nanox.ARC systems in Peru under a capex model.
Why It Matters
The agreement to deploy Nanox.ARC systems in Peru signals market expansion and potential revenue growth for Nanox, enhancing its competitive position in the medical imaging sector.
Source: GlobeNewsWire
Market Sentiment:
Neutral
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nano-X Imaging Ltd. - NNOX
17 days ago
Quick Summary
Pomerantz LLP is investigating claims on behalf of investors in Nano-X Imaging Ltd. (NASDAQ: NNOX).
Why It Matters
The investigation by Pomerantz LLP may indicate potential legal issues or financial discrepancies within Nano-X Imaging, potentially impacting stock performance and investor confidence.
Source: PRNewsWire
Market Sentiment:
Neutral
NNOX INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Nano-X Imaging Ltd.
1 month ago
Quick Summary
Kirby McInerney LLP is investigating Nano-X Imaging Ltd. (NASDAQ:NNOX) for potential violations of federal securities laws by the company and its senior management.
Why It Matters
Investigation into Nano-X could signal potential legal issues, impacting stock performance, investor confidence, and overall market perception of the company.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Wolf Haldenstein Adler Freeman & Herz LLP is investigating potential securities fraud claims against Nano-X Imaging Ltd. (NASDAQ: NNOX) involving the company and its executives.
Why It Matters
The investigation into Nano-X for potential securities fraud raises concerns about the company's governance and could impact stock performance and investor confidence.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Nanox Announces Distribution Agreement with NuvioDx to Support Deployment of Nanox.ARC Systems
1 month ago
Quick Summary
Nanox Imaging Ltd. (NASDAQ: NNOX) announced a distribution agreement with NuvioDx LLC to enhance the deployment of its Nanox.ARC systems in the U.S.
Why It Matters
Nanox's distribution agreement with NuvioDx enhances its market presence and access to U.S. diagnostic imaging, potentially boosting revenue and investor confidence in growth prospects.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Kirby McInerney LLP is investigating Nano-X Imaging Ltd. (NASDAQ:NNOX) for potential violations of federal securities laws or unlawful business practices.
Why It Matters
The investigation into Nano-X may signal potential legal risks or financial repercussions, affecting stock performance and investor confidence in the company.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Frequently Asked Questions About NNOX Stock
What is Nano-X Imaging Ltd.'s (NNOX) stock forecast for 2026?
Based on our analysis of 6 Wall Street analysts, Nano-X Imaging Ltd. (NNOX) has a median price target of $7.00. The highest price target is $9.60 and the lowest is $5.00.
Is NNOX stock a good investment in 2026?
According to current analyst ratings, NNOX has 3 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $1.93. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for NNOX stock?
Wall Street analysts predict NNOX stock could reach $7.00 in the next 12 months. This represents a 262.7% increase from the current price of $1.93. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Nano-X Imaging Ltd.'s business model?
The company develops and commercializes advanced X-ray systems, including the Nanox.ARC and Nanox.CLOUD. It generates revenue through the sale of its imaging systems and cloud-based analytics services, aimed at improving healthcare delivery and early disease detection.
What is the highest forecasted price for NNOX Nano-X Imaging Ltd.?
The highest price target for NNOX is $9.60 from at , which represents a 397.4% increase from the current price of $1.93.
What is the lowest forecasted price for NNOX Nano-X Imaging Ltd.?
The lowest price target for NNOX is $5.00 from Jason Kolbert at D. Boral Capital, which represents a 159.1% increase from the current price of $1.93.
What is the overall NNOX consensus from analysts for Nano-X Imaging Ltd.?
The overall analyst consensus for NNOX is bullish. Out of 6 Wall Street analysts, 3 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $7.00.
How accurate are NNOX stock price projections?
Stock price projections, including those for Nano-X Imaging Ltd., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: June 7, 2026 5:02 PM UTC